Literature DB >> 15342989

Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.

Samuel C Blackman1, Nell S Lurain, David P Witte, Alexandra H Filipovich, Pam Groen, Mark R Schleiss.   

Abstract

The authors describe a patient with autosomal-recessive severe combined immunodeficiency (SCID) with severe, multiorgan cytomegalovirus (CMV) disease. In the face of appropriate therapy, the patient developed a 100-fold gradient in viral load across the blood-brain barrier. Disseminated disease, including pneumonitis, contributed to a fatal outcome. Serial genotypic analyses revealed multiple UL97 and UL54 (DNA polymerase) mutations that conferred phenotypic resistance to all currently licensed systemic CMV antivirals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342989     DOI: 10.1097/01.mph.0000135283.77668.6a

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

1.  Adoptive T cell therapy for the treatment of viral infections.

Authors:  Reuben J Arasaratnam; Ann M Leen
Journal:  Ann Transl Med       Date:  2015-10

2.  Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.

Authors:  Pierre Frange; Marianne Leruez-Ville
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping.

Authors:  Emilien Drouot; Jocelyne Piret; Marc H Lebel; Guy Boivin
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

4.  The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Authors:  Mark R Schleiss; David I Bernstein; Michael A McVoy; Greg Stroup; Fernando Bravo; Blaine Creasy; Alistair McGregor; Kristin Henninger; Sabine Hallenberger
Journal:  Antiviral Res       Date:  2005-01       Impact factor: 5.970

Review 5.  Congenital cytomegalovirus infection: new prospects for prevention and therapy.

Authors:  Elizabeth C Swanson; Mark R Schleiss
Journal:  Pediatr Clin North Am       Date:  2013-04       Impact factor: 3.278

6.  Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Authors:  K Yeon Choi; B Sharon; H H Balfour; K Belani; T C Pozos; M R Schleiss
Journal:  J Clin Virol       Date:  2013-05-18       Impact factor: 3.168

7.  Temporal and spatial compartmentalization of drug-resistant cytomegalovirus (CMV) in a child with CMV meningoencephalitis: implications for sampling in molecular diagnosis.

Authors:  Pierre Frange; David Boutolleau; Marianne Leruez-Ville; Fabien Touzot; Guilhem Cros; Sebastien Heritier; Despina Moshous; Benedicte Neven; Alain Fischer; Stephane Blanche
Journal:  J Clin Microbiol       Date:  2013-10-09       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.